1. Sasai, M., H. Oshiumi, K. Funami, M. Matsumoto, and T. Seya. 2010. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor of the Toll-like receptor 3/4 pathway. Molec. Immunol. 47: 1283-1291.
  2. Kubota, N., T. Ebihara, M. Matsumoto, S. Gando, and T. Seya. 2010. IL-6 and interferon-alpha induced by polyI:C-stimulated bone-marrow-derived dendritic cells regulate peripheral expansion of regulatory T cells. Biochem. Biophys. Res. Commun. 391: 1421-1426.
  3. Hirata, N., Y. Yanagawa, M. Satoh, H. Ogura, T. Ebihara, M. Noguchi, M. Matsumoto, H. Togashi, T. Seya, K. Ono?, and K. Iwabuchi. 2010. Dendritic cell-derived TNF-a is responsible for development of IL-10-producing CD4+ T cells.Cell. Immunol. 261: 37-41.
  4. Oshiumi, H., K. Sakai, M. Matsumoto, and T. Seya. 2010. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta inducing potential. Eur. J. Immunol. 40: 940-948.
  5. Akazawa, T., N. Inoue, H. Shime, K. Sugiura, K. Kodama, M. Matsumoto, and T. Seya. 2010. Adjuvant engineering for cancer immunotherapy: development of a synthetic TLR2 ligand with increased cell adhesion. Cancer Sci. 101: 1596-1603.
  6. Kasamatsu, J., H. Oshiumi, M. Matsumoto, Kasahara, and T. Seya. 2010. Phylogenetic and expression analysis of Lamprey Toll-like receptors. Dev. Comp. Immunol. 34: 855-865.
  7. Azuma, M., R. Sawahata, Y. Akao, T. Ebihara, S. Yamazaki, M. Matsumoto, M. Hashimoto, K. Fukase, Y. Fujimoto, and T. Seya. 2010. The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation. PLoS ONE 5: e12550.
  8. Tatematsu, M., A. Ishii, M. Horiuchi, H. Oshiumi, F. Inagaki, T. Seya, and M. Matsumoto. 2010. Molecular mechanism for activation of Toll/IL-1 receptor domain-containing adaptor molecule-1 (TICAM-1). J. Biol. Chem. 285: 20128-20136.
  9. Ebihara, T., M. Azuma, H. Oshiumi, J. Kasamatsu, K. Iwabuchi, K. Matsumoto, H. Saito, T. Taniguchi, M. Matsumoto, and T. Seya. 2010. Identification of a polyI:C-inducible membrane protein, that participates in dendritic cell-mediated natural killer cell activation. J. Exp. Med. 207: 2675-2687.
  10. Ehira, N., H. Oshiumi, M. Matsumoto, T. Kondo, M. Asaka and T. Seya. 2010. An embryo-specific expressing TGF-beta family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma. J. Exp. Clin. Cancer Res. 29: 135.
  11. Oshiumi, H., H. Mori, M. Ikeda, N. Kato, M. Matsumoto, O. Takeuchi, S. Akira, K. Shimotohno, and T. Seya. 2010. Hepatitis C virus (HCV) core protein promotes viral replication by abrogating IFN-b-inducing function of DEAD/H BOX 3 (DDX3) helicase. PLoS ONE. 5: e14258.
  12. Oshiumi, H., M. Miyashita, N. Inoue, M. Okabe, M. Matsumoto, and T. Seya. 2010. Essential role of Riplet in RIG-I-dependent antiviral innate immune responses. Cell host microbe. 8: 496-509.
  13. Seya, T., H. Shime, T. Ebihara, H. Oshiumi, and M. Matsumoto. 2010. Pattern-recognition receptors of innate immunity and their application to tumor immunotherapy. Cancer Sci. 101: 313-320 (review).
  14. Seya, T., 2010. Innate immunity and vaccine. Vaccine 28: 8041-8042. (preface).